AU1868195A - Cell signaling inhibitors - Google Patents
Cell signaling inhibitorsInfo
- Publication number
- AU1868195A AU1868195A AU18681/95A AU1868195A AU1868195A AU 1868195 A AU1868195 A AU 1868195A AU 18681/95 A AU18681/95 A AU 18681/95A AU 1868195 A AU1868195 A AU 1868195A AU 1868195 A AU1868195 A AU 1868195A
- Authority
- AU
- Australia
- Prior art keywords
- cell signaling
- signaling inhibitors
- inhibitors
- cell
- signaling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18849194A | 1994-01-28 | 1994-01-28 | |
| US188491 | 1994-01-28 | ||
| PCT/US1995/001037 WO1995020589A1 (en) | 1994-01-28 | 1995-01-27 | Cell signaling inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1868195A true AU1868195A (en) | 1995-08-15 |
Family
ID=22693376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18681/95A Abandoned AU1868195A (en) | 1994-01-28 | 1995-01-27 | Cell signaling inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1868195A (en) |
| WO (1) | WO1995020589A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469017B1 (en) | 1998-01-16 | 2002-10-22 | Cell Therapeutics, Inc. | Method of inhibiting interleukin-12 signaling |
| US6878715B1 (en) | 1994-02-18 | 2005-04-12 | Cell Therapeutics, Inc. | Therapeutic compounds for inhibiting interleukin-12 signals and method for using same |
| EP0814809B1 (en) * | 1994-12-13 | 2003-08-13 | Euroceltique S.A. | Aryl thioxanthines |
| WO2000061583A1 (en) * | 1995-06-07 | 2000-10-19 | Cell Therapeutics, Inc. | Xanthine derivatives and analogs as cell signaling inhibitors |
| US6248746B1 (en) | 1998-01-07 | 2001-06-19 | Euro-Celtique S.A. | 3-(arylalkyl) xanthines |
| US6586429B2 (en) | 2000-11-29 | 2003-07-01 | Cell Therapeutics, Inc. | Tricyclic fused xanthine compounds and their uses |
| US7193105B2 (en) | 2002-05-22 | 2007-03-20 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on trihalomethylcarbonyl compounds |
| US6825180B2 (en) | 2001-05-18 | 2004-11-30 | Cell Therapeutics, Inc. | Pyridopyrimidine compounds and their uses |
| CA2556073C (en) | 2004-02-14 | 2012-01-10 | Smithkline Beecham Corporation | 8-chloro-1,3-disubstituted xanthine derivatives as hm74a receptor modulators |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| KR20080034993A (en) | 2005-08-10 | 2008-04-22 | 스미스클라인 비참 코포레이션 | Xanthine derivatives as selective hm74a agonists |
| AU2018334272B2 (en) | 2017-09-15 | 2023-06-15 | Forma Therapeutics, Inc. | Tetrahydro-imidazo quinoline compositions as CBP/p300 inhibitors |
| MX2020014303A (en) | 2018-06-29 | 2021-03-25 | Forma Therapeutics Inc | Inhibiting creb binding protein (cbp). |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3258491A (en) * | 1966-06-28 | Oxidation op olefins to ketones | ||
| ES416696A1 (en) * | 1972-07-12 | 1976-02-16 | Albert Ag Chem Werke | Procedure for the preparation of oxoalcohylxantinas. (Machine-translation by Google Translate, not legally binding) |
| DE2330742C2 (en) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1- (Oxoalkyl) -3-methyl-7-alkylxanthines, process for their preparation and pharmaceuticals containing them |
| US4203927A (en) * | 1978-04-11 | 1980-05-20 | Phillips Petroleum Company | Olefin oxidation process |
| JPS5653680A (en) * | 1979-10-05 | 1981-05-13 | Hamari Yakuhin Kogyo Kk | Preparation of 1-(5'-oxohexyl)-theobromine |
| JPS5668681A (en) * | 1979-11-10 | 1981-06-09 | Nissei Kagaku Kogyosho:Kk | Preparation of xanthine derivative |
| JPS58150594A (en) * | 1982-03-03 | 1983-09-07 | Daito Koeki Kk | Preparation of xanthine derivative |
-
1995
- 1995-01-27 WO PCT/US1995/001037 patent/WO1995020589A1/en active Search and Examination
- 1995-01-27 AU AU18681/95A patent/AU1868195A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995020589A1 (en) | 1995-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL324491A1 (en) | Cell adhesion inhibitors | |
| AU3832895A (en) | Thrombin inhibitors | |
| AU4269896A (en) | Fibronectin adhesion inhibitors | |
| AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
| EP0835109A4 (en) | Pyridinone-thrombin inhibitors | |
| AU1817095A (en) | Block copolymers | |
| IL125126A (en) | Electroconversion cell | |
| PL321759A1 (en) | Novel thrombosin inhibitors | |
| AU6138594A (en) | Electrochemical fulleren system | |
| AU1868195A (en) | Cell signaling inhibitors | |
| AU6090594A (en) | Angiotensin ii inhibitors | |
| AU692123B2 (en) | 5alpha-reductase inhibitors | |
| AU1614595A (en) | Battery | |
| AU2832399A (en) | B cell inhibitors | |
| AU6702894A (en) | Ring-substituted cell signaling inhibitors | |
| GB9425701D0 (en) | Enzyme inhibitors | |
| HU9503783D0 (en) | Squvalen syntetase inhibitors | |
| AU693274B2 (en) | Air-droppable buoy | |
| AU1013997A (en) | Amylase inhibitors | |
| AU3923395A (en) | Order-picking cell | |
| AU6049796A (en) | Lysyloxidase inhibitors | |
| AU2812195A (en) | Inhibitor | |
| AU4415597A (en) | Kshv positive cell lines | |
| AU3988895A (en) | Power line signalling system | |
| AU8159594A (en) | Novel inhibitor |